The association between vasomotor symptoms and metabolic health in peri- and postmenopausal women: A systematic review

Maturitas

Volumn 80, Issue 2, 2015, Pages 140-147

  Van Dijk, Gabriella M ^a   Maneva, Manuela ^a   Colpani, Veronica ^a   Dhana, Klodian ^a   Muka, Taulant ^a   Jaspers, Loes ^a   Kavousi, Maryam ^a   Franco, Oscar H ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Insulin resistance; Menopause; Metabolic syndrome; Systematic review; Type 2 diabetes; Vasomotor symptoms

Indexed keywords

ADL DISABILITY; ADULT; AGED; AGING; FEMALE; FRAILTY; HEALTH BEHAVIOR; HEALTH CARE UTILIZATION; HEALTH STATUS; HUMAN; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PHYSICAL ACTIVITY; PHYSICAL DISEASE BY BODY FUNCTION; REVIEW; SEDENTARY LIFESTYLE; SELF REPORT; ADRENERGIC SYSTEM; CLIMACTERIUM; CROSS-SECTIONAL STUDY; DIABETES MELLITUS, TYPE 2; HOT FLASHES; INSULIN RESISTANCE; METABOLIC SYNDROME X; METABOLISM; POSTMENOPAUSE; SWEATING;

SCOPUS;

CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HOT FLASHES; HUMANS; INSULIN RESISTANCE; METABOLIC SYNDROME X; PERIMENOPAUSE; POSTMENOPAUSE; SWEATING; VASOMOTOR SYSTEM;

EID: 84922596612     PISSN: 03785122     EISSN: 18734111     Source Type: Journal    
DOI: 10.1016/j.maturitas.2014.11.016     Document Type: Review

References (26)

1. van Dijk G, Kavousi M, Troup J, Franco O. Health issues for menopausal women: The top 11 conditions have common solutions. Maturitas 2014, vol. in press.
2. Avis N, Colvin A, Bromberger J, et al. Change in health-related quality of lifeover the menopausal transition in a multiethnic cohort of middle-aged women: Study of Women's Health Across the Nation. Menopause 2009;16(5): 860-9.
3. Gold E, Colvin A, Avis N, et al. Longitudinal analysis of the associationbetween vasomotor symptoms and race/ethnicity across the menopausaltransition: Study of women's health across the nation. Am J Public Health2006;96(7): 1226-35.
4. Kronenberg F. Hot flashes: Epidemiology and physiology. Ann N Y Acad Sci1990;592: 52-86, 123-133.
5. Randolph Jj, Sowers M, Bondarenko I, et al. The relationship of longitudi-nal change in reproductive hormones and vasomotor symptoms during themenopausal, transition. J Clin Endocrinol Metab 2005;90(11): 6106-12.
6. Gast G, Pop V, Samsioe G, et al. Vasomotor menopausal symptomsare associated with increased risk of coronary heart disease. Menopause2011;18(2): 146-51.
7. Thurston R, Sutton-Tyrell K, Everson-Rose S, Hess R, Powell L, Matthews K. Hotflashes and carotid intima media thickness among midlife women. Menopause2011;18(4): 352-8.
8. Janssen I, Powell L, Crawford S, Lasley B, Sutton-Tyrrell K. Menopause and themetabolic syndrome-The Study of Women's Health Across the Nation. ArchIntern Med 2008;168(14): 1568-75.
9. Carr M. The emergence of the metabolic syndrome with menopause. J ClinEndocrinol Metab 2003;88(6): 2404-11.
10. Polotski H, Polotski A. Metabolic implications of menopause. Semin ReprodMed 2010;28(5): 426-34.
11. Ding E, Song Y, Manson J, Rifai N, Buring J, Liu S. Plasma sex steroid hormonesand risk of developing type 2 diabetes in women: A prospective study. Dia-betologia 2007;50(10): 2076-84.
12. Otsuki M, Kasayama S, Morita S, et al. Menopause, but not age, is an independentrisk factor for fasting plasma glucose levels in nondiabetic women. Menopause2007;14(3): 404-7.
13. Sowers M, Zheng H, Tomey K, et al. Changes in body composition in womenover six years at midlife: Ovarian and chronological aging. J Clin EndocrinolMetab 2007;92(3): 895-901.
14. Gast G, Grobbee D, Pop V, et al. Menopausal complaints are associated withcardiovascular risk factors. Hypertension 2008;51(6): 1492-8.
15. Thurston R, El Khoudary S, Sutton-Tyrrell K, et al. Vasomotor symptoms andinsulin resistance in the study of women's health across the nation. J ClinEndocrinol Metab 2012;97(10): 3487-94.
16. G. Wells, B. Shea, D. O'Connel, J. Peterson, V. Welch and M. Losos, "The Newcastle-Ottawa scale (NOS) for assessing the quality of nonran-domised studies in meta-analyses [Online]. Available from: Http://www.ohri.ca/programs/clinical epidemiology/oxford.asp.
17. Herber-Gast G, Mishra G. Early severe vasomotor menopausal symptoms areassociated with diabetes. Menopause 2014;21(8): 855-60.
18. Tuomiskoski P, Ylikorkala O, Mikkola T. Menopausal hot flashes and insulinresistance. Menopause 2012;19(10): 1116-20.
19. Lee S, Jo H, Kim M, Kwon D, You Y, Kim J. Association between menopausalsymptoms and metabolic syndrome in postmenopausal women. Arch GynecolObstet 2012;285(2): 541-8.
20. Hauser G, Huber I, Keller P, Lauritzen C, Schneider H. Evaluation of climactericsymptoms (Menopause Rating Scale). Zentralbl Gynakol 1994;116: 16-23.
21. Carpenter J, Monahan P, Azzouz F. Accuracy of subjective hot flush reports com-pared with continuous sternal skin conductance monitoring. Obstet Gynecol2004;104(6): 1322-6.
22. Freedman R. Physiology of hot flashes. Am J Human Biol 2001;13(4): 453-64.
23. Lambert G, Straznicky N, Lambert E, Dixon J, Schlaich M. Sympathetic nervousactivation in obesity and the metabolic syndrome-causes, consequences andtherapeutic implications. Pharmacol Ther 2010;126(2): 159-72.
24. Carnethon M, Golden S, Folsom A, Haskell W, Liao D. Prospective investigationof autonomic nervous system function and the development of type 2 diabetes: The atherosclerosis risk in community study. Circulation 2003;107(17): 2190-5.
25. Thurston R, El Khoudary S, Sutton-Tyrrell K, et al. Are vasomotor symp-toms associated with alterations in hemostatic and inflammatory markers?Findings from the study of Women's Health across the Nation. Menopause2011;18(10): 1044-51.
26. Grassi G, Dell'Orro R, Facchini A, Quarti Trevano F, Bolla G, Mancia G. Effectof central and peripheral body fat distribution on sympathetic and baroreflexfunction in obese normotensives. J Hypertens 2004;22(12): 2363-9.